SG Americas Securities
WST icon

SG Americas Securities’s West Pharmaceutical WST Stock Holding History

SG Americas Securities’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.73M Sell
13,188
-100,856
-88% -$30.8M ﹤0.01% 1115
2026
Q1 		$28.6M Buy
114,044
+13,135
+13% +$3.27M 0.03% 422
2025
Q4 		$27.8M Buy
100,909
+74,245
+278% +$20.3M 0.04% 387
2025
Q3 		$7M Buy
26,664
+22,946
+617% +$5.58M 0.02% 411
2025
Q2 		$813K Buy
3,718
+365
+11% +$78K ﹤0.01% 1312
2025
Q1 		$751K Buy
3,353
+2,560
+323% +$706K ﹤0.01% 1424
2024
Q4 		$260K Sell
793
-3,940
-83% -$1.24M ﹤0.01% 1919
2024
Q3 		$1.42M Sell
4,733
-3,768
-44% -$1.15M 0.01% 835
2024
Q2 		$2.8M Sell
8,501
-3,864
-31% -$1.37M 0.02% 802
2024
Q1 		$4.89M Buy
12,365
+3,802
+44% +$1.41M 0.02% 556
2023
Q4 		$3.02M Sell
8,563
-19,725
-70% -$6.98M 0.03% 504
2023
Q3 		$10.6M Buy
28,288
+24,036
+565% +$9.3M 0.12% 157
2023
Q2 		$1.63M Buy
4,252
+1,856
+77% +$663K 0.01% 836
2023
Q1 		$830K Sell
2,396
-3,890
-62% -$1.14M 0.01% 1280
2022
Q4 		$1.48M Sell
6,286
-4,632
-42% -$1.1M 0.02% 725
2022
Q3 		$2.69M Buy
10,918
+2,389
+28% +$728K 0.03% 459
2022
Q2 		$2.58M Buy
8,529
+1,470
+21% +$478K 0.03% 601
2022
Q1 		$2.9M Buy
7,059
+982
+16% +$384K 0.02% 684
2021
Q4 		$2.85M Buy
6,077
+39
+0.6% +$16.8K 0.02% 819
2021
Q3 		$2.56M Buy
6,038
+2,868
+90% +$1.21M 0.01% 1051
2021
Q2 		$1.14M Sell
3,170
-1,291
-29% -$427K 0.01% 1480
2021
Q1 		$1.26M Sell
4,461
-3,586
-45% -$1.03M 0.01% 1367
2020
Q4 		$2.28M Buy
8,047
+6,081
+309% +$1.71M 0.01% 1013
2020
Q3 		$540K Sell
1,966
-256
-12% -$67.7K ﹤0.01% 1584
2020
Q2 		$505K Sell
2,222
-3,472
-61% -$682K ﹤0.01% 2091
2020
Q1 		$867K Sell
5,694
-105
-2% -$16.2K 0.01% 1394
2019
Q4 		$872K Sell
5,799
-203
-3% -$29.6K 0.01% 1365
2019
Q3 		$851K Buy
6,002
+232
+4% +$31.9K 0.01% 1499
2019
Q2 		$722K Buy
5,770
+513
+10% +$60.6K 0.01% 1654
2019
Q1 		$579K Sell
5,257
-6,023
-53% -$626K 0.01% 1719
2018
Q4 		$1.11M Sell
11,280
-7,948
-41% -$862K 0.01% 1251
2018
Q3 		$2.37M Buy
19,228
+8,530
+80% +$957K 0.02% 1039
2018
Q2 		$1.06M Sell
10,698
-578
-5% -$53.2K 0.01% 1379
2018
Q1 		$996K Sell
11,276
-13,059
-54% -$1.22M 0.01% 1353
2017
Q4 		$2.4M Buy
24,335
+9,058
+59% +$888K 0.02% 758
2017
Q3 		$1.47M Sell
15,277
-11,392
-43% -$1.03M 0.01% 993
2017
Q2 		$2.52M Buy
26,669
+9,580
+56% +$881K 0.02% 747
2017
Q1 		$1.4M Buy
17,089
+13,764
+414% +$1.15M 0.01% 1129
2016
Q4 		$282K Sell
3,325
-1,318
-28% -$104K ﹤0.01% 2084
2016
Q3 		$346K Sell
4,643
-16,511
-78% -$1.31M ﹤0.01% 2045
2016
Q2 		$1.6M Sell
21,154
-6,608
-24% -$481K 0.01% 985
2016
Q1 		$1.92M Buy
27,762
+5,168
+23% +$311K 0.01% 889
2015
Q4 		$1.36M Buy
+22,594
New +$1.36M 0.01% 952
2015
Q3 		– Sell
-2,044
Closed -$119K – 2758
2015
Q2 		$119K Buy
+2,044
New +$114K ﹤0.01% 2265
2015
Q1 		– Sell
-13,714
Closed -$730K – 3112
2014
Q4 		$730K Buy
13,714
+11,478
+513% +$574K ﹤0.01% 1397
2014
Q3 		$100K Buy
+2,236
New +$95K ﹤0.01% 2382
2014
Q1 		– Sell
-3,267
Closed -$160K – 2821
2013
Q4 		$160K Sell
3,267
-8,924
-73% -$418K ﹤0.01% 2156
2013
Q3 		$502K Buy
+12,191
New +$465K ﹤0.01% 1609

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SG Americas Securities's WST Position: Q2 2026 in Review

SG Americas Securities reduced its West Pharmaceutical (WST) stake by 88% in Q2 2026, selling an estimated $30.8M and leaving 13,188 shares worth $4.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

SG Americas Securities first reported a position in WST in Q3 2013 and has held it in 48 quarters since. The position peaked at $28.6M in Q1 2026. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • SG Americas Securities held 13,188 shares of West Pharmaceutical worth $4.73M as of Q2 2026.
  • SG Americas Securities sold 100,856 West Pharmaceutical shares in Q2 2026, an estimated $30.8M.
  • West Pharmaceutical made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1115 holding.
  • SG Americas Securities first reported a position in West Pharmaceutical in Q3 2013 and has held it in 48 quarters since.
  • SG Americas Securities's West Pharmaceutical position peaked at $28.6M in Q1 2026.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.